Chronic obstructive pulmonary diseases, which have increased due to smoking and ageing of the population, constitute a national health problem, the treatment of which can be expected to arouse considerable discussion in health care organisations currently preoccupied with economic problems.
Although extensive medication and easy access to treatment are often regarded as therapeutically desirable, it may be questioned whether they have any impact on objective measures such as mortality.
International recommendations for the early treatment of asthma have met with satisfaction and the asthma situation can be said to be under control, even though occurrences tend to be on the increase.
It should be noted, however, that the COPD treatment recommendations still remain to be tested and the general attitude towards treatment is still reserved, even pessimistic.
By combining data from the Finnish national hospital discharge register and register of deaths with findings regarding the use of medications, differences in the survival of asthmatic and COPD patients can be discerned between areas with different treatment practices. (...)
Mots-clés Pascal : Mortalité, Long terme, Homme, Bronchopneumopathie obstructive, Chronique, Asthme, Vieillard, Aspect économique, Traitement, Recommandation, Survie, Région, Pronostic, Appareil respiratoire pathologie, Poumon pathologie, Bronche pathologie, Epidémiologie, Finlande, Europe, Variation géographique
Mots-clés Pascal anglais : Mortality, Long term, Human, Obstructive pulmonary disease, Chronic, Asthma, Elderly, Economic aspect, Treatment, Recommendation, Survival, Region, Prognosis, Respiratory disease, Lung disease, Bronchus disease, Epidemiology, Finland, Europe, Geographical variation
Notice produite par :
Inist-CNRS - Institut de l'Information Scientifique et Technique
Cote : 98-0051405
Code Inist : 002B11B. Création : 14/05/1998.